BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 36679900)

  • 1. Macrophages as a Potential Immunotherapeutic Target in Solid Cancers.
    Mishra AK; Banday S; Bharadwaj R; Ali A; Rashid R; Kulshreshtha A; Malonia SK
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting macrophages: a novel treatment strategy in solid tumors.
    Liu M; Liu L; Song Y; Li W; Xu L
    J Transl Med; 2022 Dec; 20(1):586. PubMed ID: 36510315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Associated Macrophages: A Potential Target for Cancer Therapy.
    Tan Y; Wang M; Zhang Y; Ge S; Zhong F; Xia G; Sun C
    Front Oncol; 2021; 11():693517. PubMed ID: 34178692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of macrophages in the tumor microenvironment and tumor metabolism.
    Sadhukhan P; Seiwert TY
    Semin Immunopathol; 2023 Mar; 45(2):187-201. PubMed ID: 37002376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
    Zhan C; Jin Y; Xu X; Shao J; Jin C
    Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
    Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
    J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
    Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
    Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cross-talk between macrophages and tumor cells as a target for cancer treatment.
    Aizaz M; Khan A; Khan F; Khan M; Musad Saleh EA; Nisar M; Baran N
    Front Oncol; 2023; 13():1259034. PubMed ID: 38033495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Macrophages in Cancer: From Bench to Bedside.
    Poh AR; Ernst M
    Front Oncol; 2018; 8():49. PubMed ID: 29594035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages: implications in cancer immunotherapy.
    Petty AJ; Yang Y
    Immunotherapy; 2017 Mar; 9(3):289-302. PubMed ID: 28231720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing anti-tumor and tumor-tropism functions of macrophages via nanotechnology for tumor immunotherapy.
    Zheng Y; Han Y; Sun Q; Li Z
    Exploration (Beijing); 2022 Jun; 2(3):20210166. PubMed ID: 37323705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
    Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing tumor-associated macrophages as aids for cancer immunotherapy.
    Li X; Liu R; Su X; Pan Y; Han X; Shao C; Shi Y
    Mol Cancer; 2019 Dec; 18(1):177. PubMed ID: 31805946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages in liver cancer: From mechanisms to therapy.
    Cheng K; Cai N; Zhu J; Yang X; Liang H; Zhang W
    Cancer Commun (Lond); 2022 Nov; 42(11):1112-1140. PubMed ID: 36069342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer.
    Liu J; Lu J; Wu L; Zhang T; Wu J; Li L; Tai Z; Chen Z; Zhu Q
    J Adv Res; 2024 Jan; ():. PubMed ID: 38242529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiative action of tumor-associated macrophage during tumor metastasis.
    Singh S; Mehta N; Lilan J; Budhthoki MB; Chao F; Yong L
    Biochim Open; 2017 Jun; 4():8-18. PubMed ID: 29450136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.